Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2012-003577-26Phase 4Completed
Phase 4, single-arm trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Aarhus University Hospital. Primary endpoint: Impact of single-dose liraglutide on glomerular filtration rate. Started Sep 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2012-003577-26.